(Total Views: 313)
Posted On: 11/19/2019 7:08:35 AM
Post# of 145903
If the basket trial shows effect of Leronlimab on other cancers, as soon as Leronlimab is approved for combo for HIV-1, its use off-label for cancers could explode. CYDY should not talk about it, but the order of activities goes in that direction. Not to mention that in this case, after a few weeks, we know if Leronlimab works, because otherwise it all takes a very long time, these are incredible things.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)